organization

RHOVAC

RHOVAC APS
  • project . 2019 - 2022
    Funder: EC Project Code: 879817
    Overall Budget: 5,273,880 EURFunder Contribution: 2,499,900 EUR
    Open Access mandate for Publications
    Partners: RHOVAC

    Prostate cancer is the most commonly diagnosed cancer in men, with 1.7M new cases and 0.5M deaths anticipated by 2030 worldwide. Although metastases are responsible in 90% of cancer deaths, in today’s standard treatment there is no active therapy after removal of primar...

  • project . 2018 - 2018
    Funder: EC Project Code: 816773
    Overall Budget: 71,429 EURFunder Contribution: 50,000 EUR
    Open Access mandate for Publications
    Partners: RHOVAC

    Prostate cancer is the most commonly diagnosed cancer among men, with an anticipated 1.7M new cases and 499,000 deaths by 2030 worldwide. Although, most cancer therapies available focus on treatment of the primary tumor, the leading cause of cancer morbidity and mortali...

Any information missing or wrong?Report an Issue